openPR Logo
Press release

Global Myasthenia Gravis Treatment Market: Rising from $1.55 Billion in 2024 to $2.26 Billion in 2029 at a CAGR of 8.0%

01-27-2025 11:19 AM CET | Health & Medicine

Press release from: The Business Research Company

Myasthenia Gravis Treatment Market

Myasthenia Gravis Treatment Market

With a steady growth driven by cholinesterase inhibitors, thymectomy procedures, and immunosuppressive therapies, the myasthenia gravis treatment market promises a strong development in years to come.

What Is The Projected Market Size Of The Global Myasthenia Gravis Treatment Market And Its Growth Rate?
• The myasthenia gravis treatment market growth from $1.55 billion in 2024 to $1.66 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%.
• The market size is expected to reach $2.26 billion in 2029 at a CAGR of 8.0%.
• The growth in the forecast period can be attributed to biologics and monoclonal antibodies, genetic and precision medicine, emerging immune modulators, neuroprotective strategies, and biosimilar medications.

What Is Driving The Growth In The Myasthenia Gravis Treatment Market?
The myasthenia gravis treatment market's rapid growth is primarily driven by the increasing occurrence of myasthenia gravis. This is an autoimmune neuromuscular disease where patients encounter fatigue and weakness in their skeletal muscles. As such, the augmenting prevalence of this disease is promoting sales in the myasthenia gravis treatment market.
For instance, in January 2022, the National Organization for Rare Disorders revealed that autoimmune myasthenia gravis had an estimated prevalence of 14-40 per 100,000 individuals in the United States. Additionally, in April 2024, the American Journal of Managed Care reported an annual incidence rate of 4.32 cases per 100,000 individuals and a rate of 2.46 cases per 100,000 person-years, based on an average of 1,800 diagnoses of myasthenia gravis annually. These figures underline the mounting prevalence of myasthenia gravis, thereby supporting the growth of the myasthenia gravis treatment market.

Request A Free Sample Copy by clicking the link here: https://www.thebusinessresearchcompany.com/sample.aspx?id=11980&type=smp

Who Are the Key Players Driving Myasthenia Gravis Treatment Market Growth?
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Novartis AG
• AstraZeneca plc
• Takeda Pharmaceutical Company Limited
• Baxter International Inc.
• Biogen Idec
• Astellas Pharma Inc.
• CSL Limited
• Chugai Pharmaceutical Co. Ltd.
• Grifols S.A
• UCB Inc.
• Mitsubishi Tanabe Pharma Corp.
• Genentech Inc.
• Horizon Therapeutics plc
• Amneal Pharmaceuticals Inc.
• Kedrion SpA
• CuraVac Inc.
• AryoGen Pharmed
• RemeGen Co. Ltd.
• Kashiv BioSciences LLC
• Immunovant Inc.
• Cabaletta Bio Inc.
• Argenx SE
• NMD Pharma A/S
• Cartesian Therapeutics Inc.
• DAS Therapeutics Inc.
• Harbour BioMed Holdings Ltd.
• AnTolRx Inc.
• CytoDyn Inc.
• Ahead Therapeutics

What Are The Key Trends In The Myasthenia Gravis Treatment Market?
• Adoption of digital therapeutics
• Increased collaborative research initiatives
• Emphasis on patient-centric approaches
• Utilization of real-world evidence
• Enhanced long-term safety monitoring

What Are The Segments Of The Global Myasthenia Gravis Treatment Market?
• By Treatment: Medication, Surgery, Other Treatments
• By Medication Type: Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, Other Medication Types
• By End-Use: Hospitals, Clinics, Other End-Uses

Which Region Leads The Myasthenia Gravis Treatment Market?
North America was the largest region in the myasthenia gravis treatment market in 2024. The fast-growing region in the forecast period is expected to be Asia-Pacific. The report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery on this link: https://www.thebusinessresearchcompany.com/report/myasthenia-gravis-treatment-global-market-report

What Is Covered In The Myasthenia Gravis Treatment Market Global Market Report?
- Market Size Analysis: Analyze the Myasthenia Gravis Treatment Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Myasthenia Gravis Treatment Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Myasthenia Gravis Treatment Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Myasthenia Gravis Treatment Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Customization for This Report by clicking the link here: https://www.thebusinessresearchcompany.com/customise?id=11980&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Myasthenia Gravis Treatment Market: Rising from $1.55 Billion in 2024 to $2.26 Billion in 2029 at a CAGR of 8.0% here

News-ID: 3834315 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any